APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Human Transforming Growth Factor-β

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Recombinant Human Transforming Growth Factor-β Market Outlook and Growth Opportunities 2026

26 December 2025214 pages

Choose your research edition.

Industry ResearchRecombinant Human Transforming Growth Factor-β Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Human Transforming Growth Factor-β Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Recombinant Human Transforming Growth Factor-β Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Human Transforming Growth Factor-β Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Human Transforming Growth Factor-β Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Recombinant Human Transforming Growth Factor-β market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Recombinant Human Transforming Growth Factor-β is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Recombinant Human Transforming Growth Factor-β is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Human Transforming Growth Factor-β is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Recombinant Human Transforming Growth Factor-β market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Recombinant Human Transforming Growth Factor-β market include Abcam, ACROBiosystems, Atlantis Bioscience, Bio-Techne, Cell Guidance Systems, Cell Signaling Technology, Croyez Bioscience, FUJIFILM Irvine Scientific and MedChemExpress, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Recombinant Human Transforming Growth Factor-β market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Recombinant Human Transforming Growth Factor-β and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Recombinant Human Transforming Growth Factor-β sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Recombinant Human Transforming Growth Factor-β market size, projected growth trends, production technologies, key applications, and end-use industries.

Recombinant Human Transforming Growth Factor-β Segment by Company

Abcam

ACROBiosystems

Atlantis Bioscience

Bio-Techne

Cell Guidance Systems

Cell Signaling Technology

Croyez Bioscience

FUJIFILM Irvine Scientific

MedChemExpress

Miltenyi Biotec

Proteintech

Qkine

Sigma-Aldrich

Beijing T&L Biotechnology

Beijing Sino Biological

Dalian Meilun Biotechnology

Cellverse

Nanjing Okay Biotechnology

Thermo Fisher

Shanghai DiLab Biotechnology

Shanghai Zhong Qiao Xin Zhou Biotechnology

Suzhou Novoprotein Scientific

Abbkine Scientific

EIAAB SCIENCE

Yeasen Biotechnology (Shanghai)

Recombinant Human Transforming Growth Factor-β Segment by Type

TGF-β3

TGF-β2

TGF-β1

Recombinant Human Transforming Growth Factor-β Segment by Application

Hospital

Research Institute

Others

Recombinant Human Transforming Growth Factor-β Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Recombinant Human Transforming Growth Factor-β status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Recombinant Human Transforming Growth Factor-β market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Recombinant Human Transforming Growth Factor-β significant trends, drivers, influence factors in global and regions.

6. To analyze Recombinant Human Transforming Growth Factor-β competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human Transforming Growth Factor-β market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human Transforming Growth Factor-β and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human Transforming Growth Factor-β.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Recombinant Human Transforming Growth Factor-β market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Recombinant Human Transforming Growth Factor-β industry.

Chapter 3: Detailed analysis of Recombinant Human Transforming Growth Factor-β manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Recombinant Human Transforming Growth Factor-β in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Recombinant Human Transforming Growth Factor-β in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Recombinant Human Transforming Growth Factor-β Industry Trends Table 2. Recombinant Human Transforming Growth Factor-β Industry Drivers Table 3. Recombinant Human Transforming Growth Factor-β Industry Opportunities and Challenges Table 4. Recombinant Human Transforming Growth Factor-β Industry Restraints Table 5. Global Recombinant Human Transforming Growth Factor-β Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Recombinant Human Transforming Growth Factor-β Revenue Share by Company (2021-2026) Table 7. Global Recombinant Human Transforming Growth Factor-β Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Recombinant Human Transforming Growth Factor-β Sales Volume Share by Company (2021-2026) Table 9. Global Recombinant Human Transforming Growth Factor-β Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Recombinant Human Transforming Growth Factor-β Company Ranking, (2024-2026) & (USD Million) Table 11. Global Recombinant Human Transforming Growth Factor-β Key Company Manufacturing Base & Headquarters Table 12. Global Recombinant Human Transforming Growth Factor-β Company, Product Type & Application Table 13. Global Recombinant Human Transforming Growth Factor-β Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Recombinant Human Transforming Growth Factor-β by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of TGF-β3 Table 18. Significant Companies of TGF-β2 Table 19. Significant Companies of TGF-β1 Table 20. Global Recombinant Human Transforming Growth Factor-β Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Recombinant Human Transforming Growth Factor-β Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Recombinant Human Transforming Growth Factor-β Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Recombinant Human Transforming Growth Factor-β Sales Volume Share by Type (2021-2026) Table 24. Global Recombinant Human Transforming Growth Factor-β Sales Volume Share by Type (2027-2032) Table 25. Global Recombinant Human Transforming Growth Factor-β Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Recombinant Human Transforming Growth Factor-β Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Recombinant Human Transforming Growth Factor-β Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Recombinant Human Transforming Growth Factor-β Sales Value Share by Type (2021-2026) Table 29. Global Recombinant Human Transforming Growth Factor-β Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Research Institute Table 32. Significant Companies of Others Table 33. Global Recombinant Human Transforming Growth Factor-β Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Recombinant Human Transforming Growth Factor-β Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Recombinant Human Transforming Growth Factor-β Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Recombinant Human Transforming Growth Factor-β Sales Volume Share by Application (2021-2026) Table 37. Global Recombinant Human Transforming Growth Factor-β Sales Volume Share by Application (2027-2032) Table 38. Global Recombinant Human Transforming Growth Factor-β Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Recombinant Human Transforming Growth Factor-β Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Recombinant Human Transforming Growth Factor-β Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Recombinant Human Transforming Growth Factor-β Sales Value Share by Application (2021-2026) Table 42. Global Recombinant Human Transforming Growth Factor-β Sales Value Share by Application (2027-2032) Table 43. Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Recombinant Human Transforming Growth Factor-β Sales by Region (2021-2026) & (K Units) Table 45. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Region (2021-2026) Table 46. Global Recombinant Human Transforming Growth Factor-β Sales by Region (2027-2032) & (K Units) Table 47. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Region (2027-2032) Table 48. Global Recombinant Human Transforming Growth Factor-β Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Recombinant Human Transforming Growth Factor-β Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Recombinant Human Transforming Growth Factor-β Sales Value Share by Region (2021-2026) Table 51. Global Recombinant Human Transforming Growth Factor-β Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Recombinant Human Transforming Growth Factor-β Sales Value Share by Region (2027-2032) Table 53. Global Recombinant Human Transforming Growth Factor-β Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Recombinant Human Transforming Growth Factor-β Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Recombinant Human Transforming Growth Factor-β Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Recombinant Human Transforming Growth Factor-β Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 58. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021-2026) Table 59. Global Recombinant Human Transforming Growth Factor-β Sales by Country (2027-2032) & (K Units) Table 60. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2027-2032) Table 61. Global Recombinant Human Transforming Growth Factor-β Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Recombinant Human Transforming Growth Factor-β Sales Value Market Share by Country (2021-2026) Table 63. Global Recombinant Human Transforming Growth Factor-β Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Recombinant Human Transforming Growth Factor-β Sales Value Market Share by Country (2027-2032) Table 65. Abcam Company Information Table 66. Abcam Business Overview Table 67. Abcam Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Abcam Recombinant Human Transforming Growth Factor-β Product Portfolio Table 69. Abcam Recent Development Table 70. ACROBiosystems Company Information Table 71. ACROBiosystems Business Overview Table 72. ACROBiosystems Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. ACROBiosystems Recombinant Human Transforming Growth Factor-β Product Portfolio Table 74. ACROBiosystems Recent Development Table 75. Atlantis Bioscience Company Information Table 76. Atlantis Bioscience Business Overview Table 77. Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio Table 79. Atlantis Bioscience Recent Development Table 80. Bio-Techne Company Information Table 81. Bio-Techne Business Overview Table 82. Bio-Techne Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Bio-Techne Recombinant Human Transforming Growth Factor-β Product Portfolio Table 84. Bio-Techne Recent Development Table 85. Cell Guidance Systems Company Information Table 86. Cell Guidance Systems Business Overview Table 87. Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Product Portfolio Table 89. Cell Guidance Systems Recent Development Table 90. Cell Signaling Technology Company Information Table 91. Cell Signaling Technology Business Overview Table 92. Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 94. Cell Signaling Technology Recent Development Table 95. Croyez Bioscience Company Information Table 96. Croyez Bioscience Business Overview Table 97. Croyez Bioscience Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Croyez Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio Table 99. Croyez Bioscience Recent Development Table 100. FUJIFILM Irvine Scientific Company Information Table 101. FUJIFILM Irvine Scientific Business Overview Table 102. FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio Table 104. FUJIFILM Irvine Scientific Recent Development Table 105. MedChemExpress Company Information Table 106. MedChemExpress Business Overview Table 107. MedChemExpress Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. MedChemExpress Recombinant Human Transforming Growth Factor-β Product Portfolio Table 109. MedChemExpress Recent Development Table 110. Miltenyi Biotec Company Information Table 111. Miltenyi Biotec Business Overview Table 112. Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Product Portfolio Table 114. Miltenyi Biotec Recent Development Table 115. Proteintech Company Information Table 116. Proteintech Business Overview Table 117. Proteintech Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Proteintech Recombinant Human Transforming Growth Factor-β Product Portfolio Table 119. Proteintech Recent Development Table 120. Qkine Company Information Table 121. Qkine Business Overview Table 122. Qkine Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Qkine Recombinant Human Transforming Growth Factor-β Product Portfolio Table 124. Qkine Recent Development Table 125. Sigma-Aldrich Company Information Table 126. Sigma-Aldrich Business Overview Table 127. Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Product Portfolio Table 129. Sigma-Aldrich Recent Development Table 130. Beijing T&L Biotechnology Company Information Table 131. Beijing T&L Biotechnology Business Overview Table 132. Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 134. Beijing T&L Biotechnology Recent Development Table 135. Beijing Sino Biological Company Information Table 136. Beijing Sino Biological Business Overview Table 137. Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Product Portfolio Table 139. Beijing Sino Biological Recent Development Table 140. Dalian Meilun Biotechnology Company Information Table 141. Dalian Meilun Biotechnology Business Overview Table 142. Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 144. Dalian Meilun Biotechnology Recent Development Table 145. Cellverse Company Information Table 146. Cellverse Business Overview Table 147. Cellverse Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Cellverse Recombinant Human Transforming Growth Factor-β Product Portfolio Table 149. Cellverse Recent Development Table 150. Nanjing Okay Biotechnology Company Information Table 151. Nanjing Okay Biotechnology Business Overview Table 152. Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 154. Nanjing Okay Biotechnology Recent Development Table 155. Thermo Fisher Company Information Table 156. Thermo Fisher Business Overview Table 157. Thermo Fisher Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. Thermo Fisher Recombinant Human Transforming Growth Factor-β Product Portfolio Table 159. Thermo Fisher Recent Development Table 160. Shanghai DiLab Biotechnology Company Information Table 161. Shanghai DiLab Biotechnology Business Overview Table 162. Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 164. Shanghai DiLab Biotechnology Recent Development Table 165. Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information Table 166. Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview Table 167. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 169. Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Development Table 170. Suzhou Novoprotein Scientific Company Information Table 171. Suzhou Novoprotein Scientific Business Overview Table 172. Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 173. Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio Table 174. Suzhou Novoprotein Scientific Recent Development Table 175. Abbkine Scientific Company Information Table 176. Abbkine Scientific Business Overview Table 177. Abbkine Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 178. Abbkine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio Table 179. Abbkine Scientific Recent Development Table 180. EIAAB SCIENCE Company Information Table 181. EIAAB SCIENCE Business Overview Table 182. EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 183. EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Product Portfolio Table 184. EIAAB SCIENCE Recent Development Table 185. Yeasen Biotechnology (Shanghai) Company Information Table 186. Yeasen Biotechnology (Shanghai) Business Overview Table 187. Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 188. Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Product Portfolio Table 189. Yeasen Biotechnology (Shanghai) Recent Development Table 190. Key Raw Materials Table 191. Raw Materials Key Suppliers Table 192. Recombinant Human Transforming Growth Factor-β Distributors List Table 193. Recombinant Human Transforming Growth Factor-β Customers List Table 194. Research Programs/Design for This Report Table 195. Authors List of This Report Table 196. Secondary Sources Table 197. Primary Sources List of Figures Figure 1. Recombinant Human Transforming Growth Factor-β Product Image Figure 2. Global Recombinant Human Transforming Growth Factor-β Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Human Transforming Growth Factor-β Sales Value (2021-2032) & (US$ Million) Figure 4. Global Recombinant Human Transforming Growth Factor-β Sales (2021-2032) & (K Units) Figure 5. Global Recombinant Human Transforming Growth Factor-β Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Recombinant Human Transforming Growth Factor-β Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. TGF-β3 Image Figure 10. TGF-β2 Image Figure 11. TGF-β1 Image Figure 12. Global Recombinant Human Transforming Growth Factor-β Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Recombinant Human Transforming Growth Factor-β Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Recombinant Human Transforming Growth Factor-β Sales Volume Share by Type (2021-2032) Figure 15. Global Recombinant Human Transforming Growth Factor-β Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Recombinant Human Transforming Growth Factor-β Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Recombinant Human Transforming Growth Factor-β Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Research Institute Image Figure 20. Others Image Figure 21. Global Recombinant Human Transforming Growth Factor-β Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Recombinant Human Transforming Growth Factor-β Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Recombinant Human Transforming Growth Factor-β Sales Volume Share by Application (2021-2032) Figure 24. Global Recombinant Human Transforming Growth Factor-β Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Recombinant Human Transforming Growth Factor-β Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Recombinant Human Transforming Growth Factor-β Sales Value Share by Application (2021-2032) Figure 27. Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Recombinant Human Transforming Growth Factor-β Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Recombinant Human Transforming Growth Factor-β Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Recombinant Human Transforming Growth Factor-β Sales Value (2021-2032) & (US$ Million) Figure 32. North America Recombinant Human Transforming Growth Factor-β Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Recombinant Human Transforming Growth Factor-β Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Recombinant Human Transforming Growth Factor-β Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Recombinant Human Transforming Growth Factor-β Sales Value (2021-2032) & (US$ Million) Figure 38. South America Recombinant Human Transforming Growth Factor-β Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Recombinant Human Transforming Growth Factor-β Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Recombinant Human Transforming Growth Factor-β Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Recombinant Human Transforming Growth Factor-β Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Recombinant Human Transforming Growth Factor-β Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • TGF-β3
  • TGF-β2
  • TGF-β1
Applications
  • Hospital
  • Research Institute
  • Others
Companies covered
  • Abcam
  • ACROBiosystems
  • Atlantis Bioscience
  • Bio-Techne
  • Cell Guidance Systems
  • Cell Signaling Technology
  • Croyez Bioscience
  • FUJIFILM Irvine Scientific
  • MedChemExpress
  • Miltenyi Biotec
  • Proteintech
  • Qkine
  • Sigma-Aldrich
  • Beijing T&L Biotechnology
  • Beijing Sino Biological
  • Dalian Meilun Biotechnology
  • Cellverse
  • Nanjing Okay Biotechnology
  • Thermo Fisher
  • Shanghai DiLab Biotechnology
  • Shanghai Zhong Qiao Xin Zhou Biotechnology
  • Suzhou Novoprotein Scientific
  • Abbkine Scientific
  • EIAAB SCIENCE
  • Yeasen Biotechnology (Shanghai)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant Human Transforming Growth Factor-β Sales Value (2021-2032)
  4. 1.2.2 Global Recombinant Human Transforming Growth Factor-β Sales Volume (2021-2032)
  5. 1.2.3 Global Recombinant Human Transforming Growth Factor-β Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Recombinant Human Transforming Growth Factor-β Market Dynamics
  1. 2.1 Recombinant Human Transforming Growth Factor-β Industry Trends
  2. 2.2 Recombinant Human Transforming Growth Factor-β Industry Drivers
  3. 2.3 Recombinant Human Transforming Growth Factor-β Industry Opportunities and Challenges
  4. 2.4 Recombinant Human Transforming Growth Factor-β Industry Restraints
3 Recombinant Human Transforming Growth Factor-β Market by Company
  1. 3.1 Global Recombinant Human Transforming Growth Factor-β Company Revenue Ranking in 2025
  2. 3.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Company (2021-2026)
  3. 3.3 Global Recombinant Human Transforming Growth Factor-β Sales Volume by Company (2021-2026)
  4. 3.4 Global Recombinant Human Transforming Growth Factor-β Average Price by Company (2021-2026)
  5. 3.5 Global Recombinant Human Transforming Growth Factor-β Company Ranking (2024-2026)
  6. 3.6 Global Recombinant Human Transforming Growth Factor-β Company Manufacturing Base and Headquarters
  7. 3.7 Global Recombinant Human Transforming Growth Factor-β Company Product Type and Application
  8. 3.8 Global Recombinant Human Transforming Growth Factor-β Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Recombinant Human Transforming Growth Factor-β Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Recombinant Human Transforming Growth Factor-β Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Recombinant Human Transforming Growth Factor-β Market by Type
  1. 4.1 Recombinant Human Transforming Growth Factor-β Type Introduction
  2. 4.1.1 TGF-β3
  3. 4.1.2 TGF-β2
  4. 4.1.3 TGF-β1
  5. 4.2 Global Recombinant Human Transforming Growth Factor-β Sales Volume by Type
  6. 4.2.1 Global Recombinant Human Transforming Growth Factor-β Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Recombinant Human Transforming Growth Factor-β Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Recombinant Human Transforming Growth Factor-β Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Recombinant Human Transforming Growth Factor-β Sales Value by Type
  10. 4.3.1 Global Recombinant Human Transforming Growth Factor-β Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Recombinant Human Transforming Growth Factor-β Sales Value by Type (2021-2032)
  12. 4.3.3 Global Recombinant Human Transforming Growth Factor-β Sales Value Share by Type (2021-2032)
5 Recombinant Human Transforming Growth Factor-β Market by Application
  1. 5.1 Recombinant Human Transforming Growth Factor-β Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Research Institute
  4. 5.1.3 Others
  5. 5.2 Global Recombinant Human Transforming Growth Factor-β Sales Volume by Application
  6. 5.2.1 Global Recombinant Human Transforming Growth Factor-β Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Recombinant Human Transforming Growth Factor-β Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Recombinant Human Transforming Growth Factor-β Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Recombinant Human Transforming Growth Factor-β Sales Value by Application
  10. 5.3.1 Global Recombinant Human Transforming Growth Factor-β Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Recombinant Human Transforming Growth Factor-β Sales Value by Application (2021-2032)
  12. 5.3.3 Global Recombinant Human Transforming Growth Factor-β Sales Value Share by Application (2021-2032)
6 Recombinant Human Transforming Growth Factor-β Regional Sales and Value Analysis
  1. 6.1 Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Recombinant Human Transforming Growth Factor-β Sales by Region (2021-2032)
  3. 6.2.1 Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2021-2026
  4. 6.2.2 Global Recombinant Human Transforming Growth Factor-β Sales by Region (2027-2032)
  5. 6.3 Global Recombinant Human Transforming Growth Factor-β Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Recombinant Human Transforming Growth Factor-β Sales Value by Region (2021-2032)
  7. 6.4.1 Global Recombinant Human Transforming Growth Factor-β Sales Value by Region: 2021-2026
  8. 6.4.2 Global Recombinant Human Transforming Growth Factor-β Sales Value by Region (2027-2032)
  9. 6.5 Global Recombinant Human Transforming Growth Factor-β Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Recombinant Human Transforming Growth Factor-β Sales Value (2021-2032)
  12. 6.6.2 North America Recombinant Human Transforming Growth Factor-β Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Recombinant Human Transforming Growth Factor-β Sales Value (2021-2032)
  15. 6.7.2 Europe Recombinant Human Transforming Growth Factor-β Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Recombinant Human Transforming Growth Factor-β Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Recombinant Human Transforming Growth Factor-β Sales Value (2021-2032)
  21. 6.9.2 South America Recombinant Human Transforming Growth Factor-β Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Recombinant Human Transforming Growth Factor-β Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Recombinant Human Transforming Growth Factor-β Sales Value Share by Country, 2025 VS 2032
7 Recombinant Human Transforming Growth Factor-β Country-level Sales and Value Analysis
  1. 7.1 Global Recombinant Human Transforming Growth Factor-β Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Recombinant Human Transforming Growth Factor-β Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2032)
  4. 7.3.1 Global Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026)
  5. 7.3.2 Global Recombinant Human Transforming Growth Factor-β Sales by Country (2027-2032)
  6. 7.4 Global Recombinant Human Transforming Growth Factor-β Sales Value by Country (2021-2032)
  7. 7.4.1 Global Recombinant Human Transforming Growth Factor-β Sales Value by Country (2021-2026)
  8. 7.4.2 Global Recombinant Human Transforming Growth Factor-β Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Recombinant Human Transforming Growth Factor-β Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Recombinant Human Transforming Growth Factor-β Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Recombinant Human Transforming Growth Factor-β Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abcam
  2. 8.1.1 Abcam Company Information
  3. 8.1.2 Abcam Business Overview
  4. 8.1.3 Abcam Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abcam Recombinant Human Transforming Growth Factor-β Product Portfolio
  6. 8.1.5 Abcam Recent Developments
  7. 8.2 ACROBiosystems
  8. 8.2.1 ACROBiosystems Company Information
  9. 8.2.2 ACROBiosystems Business Overview
  10. 8.2.3 ACROBiosystems Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 ACROBiosystems Recombinant Human Transforming Growth Factor-β Product Portfolio
  12. 8.2.5 ACROBiosystems Recent Developments
  13. 8.3 Atlantis Bioscience
  14. 8.3.1 Atlantis Bioscience Company Information
  15. 8.3.2 Atlantis Bioscience Business Overview
  16. 8.3.3 Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio
  18. 8.3.5 Atlantis Bioscience Recent Developments
  19. 8.4 Bio-Techne
  20. 8.4.1 Bio-Techne Company Information
  21. 8.4.2 Bio-Techne Business Overview
  22. 8.4.3 Bio-Techne Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bio-Techne Recombinant Human Transforming Growth Factor-β Product Portfolio
  24. 8.4.5 Bio-Techne Recent Developments
  25. 8.5 Cell Guidance Systems
  26. 8.5.1 Cell Guidance Systems Company Information
  27. 8.5.2 Cell Guidance Systems Business Overview
  28. 8.5.3 Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Product Portfolio
  30. 8.5.5 Cell Guidance Systems Recent Developments
  31. 8.6 Cell Signaling Technology
  32. 8.6.1 Cell Signaling Technology Company Information
  33. 8.6.2 Cell Signaling Technology Business Overview
  34. 8.6.3 Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Product Portfolio
  36. 8.6.5 Cell Signaling Technology Recent Developments
  37. 8.7 Croyez Bioscience
  38. 8.7.1 Croyez Bioscience Company Information
  39. 8.7.2 Croyez Bioscience Business Overview
  40. 8.7.3 Croyez Bioscience Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Croyez Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio
  42. 8.7.5 Croyez Bioscience Recent Developments
  43. 8.8 FUJIFILM Irvine Scientific
  44. 8.8.1 FUJIFILM Irvine Scientific Company Information
  45. 8.8.2 FUJIFILM Irvine Scientific Business Overview
  46. 8.8.3 FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
  48. 8.8.5 FUJIFILM Irvine Scientific Recent Developments
  49. 8.9 MedChemExpress
  50. 8.9.1 MedChemExpress Company Information
  51. 8.9.2 MedChemExpress Business Overview
  52. 8.9.3 MedChemExpress Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 MedChemExpress Recombinant Human Transforming Growth Factor-β Product Portfolio
  54. 8.9.5 MedChemExpress Recent Developments
  55. 8.10 Miltenyi Biotec
  56. 8.10.1 Miltenyi Biotec Company Information
  57. 8.10.2 Miltenyi Biotec Business Overview
  58. 8.10.3 Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Product Portfolio
  60. 8.10.5 Miltenyi Biotec Recent Developments
  61. 8.11 Proteintech
  62. 8.11.1 Proteintech Company Information
  63. 8.11.2 Proteintech Business Overview
  64. 8.11.3 Proteintech Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Proteintech Recombinant Human Transforming Growth Factor-β Product Portfolio
  66. 8.11.5 Proteintech Recent Developments
  67. 8.12 Qkine
  68. 8.12.1 Qkine Company Information
  69. 8.12.2 Qkine Business Overview
  70. 8.12.3 Qkine Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Qkine Recombinant Human Transforming Growth Factor-β Product Portfolio
  72. 8.12.5 Qkine Recent Developments
  73. 8.13 Sigma-Aldrich
  74. 8.13.1 Sigma-Aldrich Company Information
  75. 8.13.2 Sigma-Aldrich Business Overview
  76. 8.13.3 Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Product Portfolio
  78. 8.13.5 Sigma-Aldrich Recent Developments
  79. 8.14 Beijing T&L Biotechnology
  80. 8.14.1 Beijing T&L Biotechnology Company Information
  81. 8.14.2 Beijing T&L Biotechnology Business Overview
  82. 8.14.3 Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  84. 8.14.5 Beijing T&L Biotechnology Recent Developments
  85. 8.15 Beijing Sino Biological
  86. 8.15.1 Beijing Sino Biological Company Information
  87. 8.15.2 Beijing Sino Biological Business Overview
  88. 8.15.3 Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Product Portfolio
  90. 8.15.5 Beijing Sino Biological Recent Developments
  91. 8.16 Dalian Meilun Biotechnology
  92. 8.16.1 Dalian Meilun Biotechnology Company Information
  93. 8.16.2 Dalian Meilun Biotechnology Business Overview
  94. 8.16.3 Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  96. 8.16.5 Dalian Meilun Biotechnology Recent Developments
  97. 8.17 Cellverse
  98. 8.17.1 Cellverse Company Information
  99. 8.17.2 Cellverse Business Overview
  100. 8.17.3 Cellverse Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Cellverse Recombinant Human Transforming Growth Factor-β Product Portfolio
  102. 8.17.5 Cellverse Recent Developments
  103. 8.18 Nanjing Okay Biotechnology
  104. 8.18.1 Nanjing Okay Biotechnology Company Information
  105. 8.18.2 Nanjing Okay Biotechnology Business Overview
  106. 8.18.3 Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  108. 8.18.5 Nanjing Okay Biotechnology Recent Developments
  109. 8.19 Thermo Fisher
  110. 8.19.1 Thermo Fisher Company Information
  111. 8.19.2 Thermo Fisher Business Overview
  112. 8.19.3 Thermo Fisher Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Thermo Fisher Recombinant Human Transforming Growth Factor-β Product Portfolio
  114. 8.19.5 Thermo Fisher Recent Developments
  115. 8.20 Shanghai DiLab Biotechnology
  116. 8.20.1 Shanghai DiLab Biotechnology Company Information
  117. 8.20.2 Shanghai DiLab Biotechnology Business Overview
  118. 8.20.3 Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  120. 8.20.5 Shanghai DiLab Biotechnology Recent Developments
  121. 8.21 Shanghai Zhong Qiao Xin Zhou Biotechnology
  122. 8.21.1 Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information
  123. 8.21.2 Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview
  124. 8.21.3 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  126. 8.21.5 Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments
  127. 8.22 Suzhou Novoprotein Scientific
  128. 8.22.1 Suzhou Novoprotein Scientific Company Information
  129. 8.22.2 Suzhou Novoprotein Scientific Business Overview
  130. 8.22.3 Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
  132. 8.22.5 Suzhou Novoprotein Scientific Recent Developments
  133. 8.23 Abbkine Scientific
  134. 8.23.1 Abbkine Scientific Company Information
  135. 8.23.2 Abbkine Scientific Business Overview
  136. 8.23.3 Abbkine Scientific Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Abbkine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
  138. 8.23.5 Abbkine Scientific Recent Developments
  139. 8.24 EIAAB SCIENCE
  140. 8.24.1 EIAAB SCIENCE Company Information
  141. 8.24.2 EIAAB SCIENCE Business Overview
  142. 8.24.3 EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Product Portfolio
  144. 8.24.5 EIAAB SCIENCE Recent Developments
  145. 8.25 Yeasen Biotechnology (Shanghai)
  146. 8.25.1 Yeasen Biotechnology (Shanghai) Company Information
  147. 8.25.2 Yeasen Biotechnology (Shanghai) Business Overview
  148. 8.25.3 Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Product Portfolio
  150. 8.25.5 Yeasen Biotechnology (Shanghai) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Recombinant Human Transforming Growth Factor-β Value Chain Analysis
  2. 9.1.1 Recombinant Human Transforming Growth Factor-β Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Recombinant Human Transforming Growth Factor-β Sales Mode & Process
  6. 9.2 Recombinant Human Transforming Growth Factor-β Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Recombinant Human Transforming Growth Factor-β Distributors
  9. 9.2.3 Recombinant Human Transforming Growth Factor-β Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst